ImageneBio Statistics
Total Valuation
ImageneBio has a market cap or net worth of $60.62 million. The enterprise value is -$73.62 million.
| Market Cap | 60.62M |
| Enterprise Value | -73.62M |
Important Dates
The last earnings date was Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ImageneBio has 11.35 million shares outstanding. The number of shares has decreased by -97.61% in one year.
| Current Share Class | 11.35M |
| Shares Outstanding | 11.35M |
| Shares Change (YoY) | -97.61% |
| Shares Change (QoQ) | +44.16% |
| Owned by Insiders (%) | 1.95% |
| Owned by Institutions (%) | 27.92% |
| Float | 5.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.47, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.47 |
| Quick Ratio | 20.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.68% and return on invested capital (ROIC) is -48.44%.
| Return on Equity (ROE) | -82.68% |
| Return on Assets (ROA) | -43.06% |
| Return on Invested Capital (ROIC) | -48.44% |
| Return on Capital Employed (ROCE) | -40.53% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.96M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -324,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.85% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -60.85% |
| 50-Day Moving Average | 5.77 |
| 200-Day Moving Average | 6.13 |
| Relative Strength Index (RSI) | 40.25 |
| Average Volume (20 Days) | 10,318 |
Short Selling Information
The latest short interest is 49,297, so 0.43% of the outstanding shares have been sold short.
| Short Interest | 49,297 |
| Short Previous Month | 384,525 |
| Short % of Shares Out | 0.43% |
| Short % of Float | 0.84% |
| Short Ratio (days to cover) | 4.47 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.96M |
| Pretax Income | -52.81M |
| Net Income | -53.33M |
| EBITDA | -58.37M |
| EBIT | -58.96M |
| Earnings Per Share (EPS) | -$4.81 |
Balance Sheet
The company has $136.15 million in cash and $1.91 million in debt, with a net cash position of $134.24 million or $11.83 per share.
| Cash & Cash Equivalents | 136.15M |
| Total Debt | 1.91M |
| Net Cash | 134.24M |
| Net Cash Per Share | $11.83 |
| Equity (Book Value) | 142.07M |
| Book Value Per Share | 12.60 |
| Working Capital | 134.54M |
Cash Flow
| Operating Cash Flow | -52.59M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 594,500 |
| Net Borrowing | n/a |
| Free Cash Flow | -52.59M |
| FCF Per Share | -$4.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ImageneBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 97.61% |
| Shareholder Yield | 97.61% |
| Earnings Yield | -87.98% |
| FCF Yield | -86.75% |
Analyst Forecast
The average price target for ImageneBio is $18.00, which is 237.08% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.00 |
| Price Target Difference | 237.08% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ImageneBio has an Altman Z-Score of 2.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 2 |